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Abstract The use of prisms in cases of decompensated
heterophoria is an established treatment modality. The
clinical literature lacks consensus upon the appropriate use
of prisms, and fails to provide the necessary evidence base.
While the experimental literature can guide the practitioner,
the lack of double-blind, placebo-controlled clinical studies
needs to be addressed.
Keywords Prisms . Binocular . Vergence adaption
The use of prisms in cases of binocular dysfunction is an
important treatment modality for dealing with such patients
[1]. The decision to prescribe a prism, and what value of
prism to give, is subject to varying clinical opinions and
practices [2]. The conservative view in clinical practice is
that prisms should not be prescribed in the absence of
symptoms of binocular dysfunction [1]. Furthermore, the
prescribing of prisms is contraindicated in certain cases,
due to the risk of exacerbating an existing condition
through the process of vergence adaptation [3–6].
The control of the vergence response has been described
previously using linear systems modelling [7], and can aid
our understanding of the aetiology of binocular visual
dysfunction, and the effect of clinical intervention. The
normal vergence response operates in a closed-loop
feedback system, where the total response is the sum of
the outputs of two control elements with differing temporal
properties; a fast (phasic) control element and a slow (tonic)
adaptive control element [7].
Previous reports have suggested that the strength of the
adaptive vergence control element is often related to the
presence of symptoms in patients with binocular dysfunction,
and in severe cases the output of the adaptive vergence
controller may be reduced to almost zero [8, 9]. In less severe
cases, vergence adaptation may be present at a sub-normal
level, but sufficient to produce an adaptive response to the
introduction of a prism [8]. In such patients, strengthening
the adaptive vergence control element is the treatment of first
choice [8, 9]. Other studies have shown that in elderly
patients vergence adaptation is very limited, and that while
this may often be the cause of binocular dysfunction in these
patients, remedial action with prisms is clinically viable
because adaptation is very unlikely [10]. Indeed, we observe
in our own binocular vision clinic that treatments designed to
improve the strength of the adaptive vergence controller are
generally unsuccessful in elderly patients.
Typical clinical measures of binocular function, three of
which are investigated by Otto et al. [11] in the current
issue, are:
1. Heterophoria (or dissociated phoria).
This represents the fusion-free position of the eyes, and
therefore the magnitude of the deviation which has to be
overcome by the vergence system.
2. Fixation disparity.
First investigated by Ogle [12], this represents a small
misalignment of the visual axes during binocular viewing,
normally measured in seconds of arc. Many clinicians take
the view that fixation disparity is indicative of stress within
the binocular system [1]. Other authors regard fixation
disparity to be a purposeful error, necessary for the
vergence control system [5].
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3. Associated heterophoria
Mallett [13, 14] is the author associated with describing
the clinical characteristics of this measurement, which
measures the amount of prism required to reduce any fixation
disparity (in 2 above) present to zero. In Mallett’s opinion, the
presence of an associated phoria in a patient with symptoms of
binocular vision dysfunction is indicative of stress within the
binocular system, and requires treatment [15].
4. Fusional vergence reserves.
This is a clinical measure of the overall ability of the
vergence system to control heterophoria. It is generally
used in the calculation of Sheard’s Criterion [16], which
requires the vergence reserves to be at least twice the size of
any heterophoria present. There is evidence that the
vergence reserves are related to the strength of the adaptive
component of the vergence system [8, 9].
Each of these measures assess one specific aspect of
binocular function, and while some practitioners prefer to rely
on a particular measure to assess binocular function, others
may assess a combination of the measures above to decide the
most appropriate clinical intervention for the patient [2].
There is a lack of consensus in the literature about which
of these measures correlates most closely with symptoms of
binocular dysfunction, and which provides the most
accurate basis for prescribing a prism when this is
appropriate. Previous work has shown that no single
measure correlates well with patient symptoms in all types
of binocular anomaly, suggesting that neither fixation
disparity, nor associated phoria, provide a universal
indicator of binocular dysfunction [17]. This work also
found that measures of vergence reserves often showed a
better correlation with symptoms [17].
The imperative question for the clinician remains; is
there a reliable method to determine the magnitude of prism
required to compensate the heterophoria in patients suitable
for this method of treatment? Mallett [15] suggested that
the associated heterophoria identified the uncompensated
portion of the binocular anomaly, and therefore this value
represented the prism required to give the patient binocular
comfort and stability. Other studies have questioned this [5,
17], and indeed the presence of an associated phoria in
patients without binocular visual problems casts doubt on
the general applicability of this measure [18]. Sheard’s
criterion provides a rationale for prescribing prisms [1, 18];
however, there is still a lack of randomised controlled
clinical trials to prove the efficacy of any treatment of
binocular vision [2], although a recent study has begun to
address this [19]. The use of a measure such as the
“comfortable prism”, while clinically appealing, is highly
subjective in nature, and would also require a clinical
evidence base to prove efficacy. There is considerable work
still to be done in the field of clinical management of
binocular vision dysfunction in order to provide the
required evidence base.
In all cases of binocular dysfunction, the choice to
prescribe prisms lies with the clinician, who must judge
what is most appropriate for each individual patient. A
relatively straightforward procedure has been described to
assess the probability of vergence adaptation occurring and
rendering any prescribed prism ineffective [20]. Where
prism treatment is being considered, obtain a prior
measurement of the associated phoria, insert the prism to
be prescribed into the trial frame and measure the
associated phoria with the prism in situ. Allow the patient
to wear the prism for 10 minutes; if the associated phoria
returns to the value measured prior to insertion of the prism,
then the patient’s vergence adaptation mechanism has been
strong enough to overcome the prism, and it will have little
clinical benefit. Conversely, if no vergence adaptation is
observed, the patient is likely to derive significant clinical
benefit from this treatment.
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